Clinical Trials Logo

Clinical Trial Summary

This clinical investigation examined the influence of cytostatic chemotherapy with 5-fluorouracil, modulated by biologically active leucovorin, on patients’ survival time following surgery for colon carcinoma Stage II.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00309543
Study type Interventional
Source Austrian Breast & Colorectal Cancer Study Group
Contact
Status Completed
Phase Phase 3
Start date November 1993

See also
  Status Clinical Trial Phase
Recruiting NCT06434896 - Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial N/A
Recruiting NCT04089631 - Circulating Tumour DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation Phase 3
Active, not recruiting NCT05421702 - Comparison Between Results of 2 Laparoscopic Surgical Procedures in Operable Colon Cancer Cases in Upper Egypt N/A
Recruiting NCT06108310 - ArTificial inTelligence-based RAdiogenomics in Colon Tumors
Recruiting NCT05194878 - Neoadjuvant FOLFOXIRI Versus Immediate Surgery for Stage II and III Colon Cancers Phase 3